Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD



Rating:

Share or cite this content

Citations should be made in the following way:
A. Guber, J. Greif, R. Ronny, E. Fireman, L. Madi, T. Kaplam, B. Pal, Z. Yemini, R. Katz, M. Gottfried, M. Daniely (Kfar Saba, Tel Aviv, Rehovot, Israel; Houston, TX, United States Of America). Lung cancer detection by computer assisted analysis of novel biomarkers in induced sputum samples. Eur Respir J 2008; 32: Suppl. 52, 3001

Member's Comments

No comment yet.

Related content which might interest you: Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Automated target-FISH lung cancer detection (LCD) test of induced sputum Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Can semi-automated image cytometry on induced sputum become a screening tool for lung cancer?: Evaluation of quantitative semi-automated sputum cytometry on radon- and uranium-exposed workers Source: Eur Respir J 2001; 18: 942-950 Year: 2001 Validation of diagnostic molecular markers in bronchial fluid for lung cancer Source: Annual Congress 2011 - Progress in endoscopy for the diagnosis of lung cancer Year: 2011 Comparative analysis of lung cancer driver mutations from FFPE samples and liquid biopsies by IonTorrent next generation sequencing Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Early detection of lung cancer through analysis of VOC biomarkers in exhaled breath: The LuCID study. Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies Year: 2017 Potential lung cancer biomarkers from bronchoalveolar lavage fluid using metabolomics approaches Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Dividing EBUS-TBNA samples for simultaneous histopathological and molecular analyses in lung cancer patients Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology Year: 2015 Validation of a deep learning-based computer-aided system for lung nodule detection in a Chinese lung cancer screening program Source: Virtual Congress 2020 – Screening and imaging in lung cancer Year: 2020 Quantification of free RNA in serum and bronchial lavage - a new tool for lung cancer detection? Source: Annual Congress 2004 - Molecular biology Year: 2004 Circulating biomarkers and tumour molecular profiling in patients with non-small cell lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 RT-PCR and IHC as the alternative methods for detection of ALK aberrations in NSCLC samples - The feasibility study Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015 Combining biopsy tools improves mutation detection rate in central lung cancer Source: ERJ Open Res, 6 (3) 00002-2020; 10.1183/23120541.00002-2020 Year: 2020 Early detection of lung cancer: role of biomarkers Source: Eur Respir J 2003; 21: 36S-44S Year: 2003 Proteomic derived biomarkers for COPD are present in induced sputum Source: Eur Respir J 2005; 26: Suppl. 49, 439s Year: 2005 Large-scale quantitative proteomic analysis identifies pathways in COPD-associated lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Optimization of cfDNA routine use for NSCLC genomic alteration analysis Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016 Exploring the 24h-effect of targeted therapies in non-small cell lung cancer from exon array blood profiling using dually constrained correspondence analysis Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Breath biomarkers for lung cancer detection: ready for use by the pulmonologist? Source: Annual Congress 2012 - PG18 Recent evolutions in screening and early diagnosis of lung cancer Year: 2012